Latest Prescription Drugs news
Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF
posted October 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
posted October 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
posted October 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs
posted October 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
